Osborne Clarke advised the majority shareholders of Exploristics Ltd on the sale. MMS, an award-winning, data-focused clinical research organization (CRO), announced its acquisition of Exploristics, a...
Osborne Clarke advised the majority shareholders of Exploristics Ltd on the sale. MMS, an award-winning, data-focused clinical research organization (CRO), announced its acquisition of Exploristics, a...
